VO2 Max on a GLP-1 During Menopause: The Number That Lies to You

VO2 max is the maximum volume of oxygen your body can take in, transport, and use during intense exercise. It is the ceiling on your aerobic capacity, and it depends on a chain of systems: how much blood your heart can pump per beat, how much oxygen your blood can carry, how well your capillaries deliver it, and how efficiently your muscle mitochondria use it.

Because it integrates all of those, it functions as a summary measure of physiological reserve — and it turns out to be a remarkably strong predictor of how long you live. The largest analysis of this comes from Mandsager and colleagues (*JAMA Network Open*, 2018), who studied 122,007 patients who underwent treadmill testing. They found a graded relationship between fitness and survival with no upper limit of benefit, and the mortality difference between the least fit and the most fit was larger than the risk associated with smoking, diabetes, or established coronary artery disease. The authors noted explicitly that low cardiorespiratory fitness should be treated as a modifiable risk factor comparable to those conditions.

That framing is worth sitting with. Most midlife health conversations focus on numbers that predict risk indirectly — cholesterol, blood pressure, glucose. VO2 max is closer to a direct readout of how much capacity your body has left, and unlike your genetics, it is trainable at every age.

The menopause angle is that this is exactly when it starts falling faster. VO2 max declines roughly 10% per decade after age 30 in sedentary adults, and the rate tends to accelerate through the menopause transition. Contributors include declining lean muscle mass, reduced stroke volume, changes in vascular compliance, and — very often — a quiet reduction in training intensity as fatigue, joint pain, and disrupted sleep make hard efforts less appealing. Our guide to [why you need more rest days in menopause](/blog/menopause-exercise-recovery-why-you-need-more-rest-days) covers the recovery side of that equation.

Because of the denominator. VO2 max is almost always reported in millilitres of oxygen per kilogram of body weight per minute (mL/kg/min). The kilograms are yours. Reduce them and the ratio rises, whether or not anything about your cardiovascular system changed.

The arithmetic is straightforward. Suppose your absolute oxygen uptake is 2.2 litres per minute and you weigh 92 kg. That is roughly 24 mL/kg/min. Lose 14 kg with no change in absolute uptake and you are now at 78 kg — the same 2.2 L/min becomes about 28 mL/kg/min. Your watch reports a 17% improvement in fitness. Your heart has done nothing new.

This is not a measurement error. Relative VO2 max is genuinely meaningful — carrying less mass really does make a given pace easier, and it is the right metric for predicting performance in weight-bearing activity. But it is not a measure of *cardiovascular adaptation*, and interpreting it as one leads people to conclude their aerobic training is working when they have not trained at all.

The complication specific to GLP-1s is what happens to the numerator. Absolute VO2 depends heavily on skeletal muscle mass, because muscle is where oxygen is consumed. In the SURMOUNT-1 body composition substudy, roughly a quarter of total weight lost on tirzepatide was lean mass; DXA substudy data from the STEP programme showed a comparable pattern with semaglutide. Losing lean mass reduces absolute oxygen uptake.

So it is entirely possible to lose meaningful weight, watch your reported VO2 max climb, and have less absolute aerobic capacity than when you started. In midlife women, who are already contending with age- and hormone-related muscle loss, that is a scenario worth taking seriously rather than celebrating.

Menopause adds a second downward pressure on the numerator, independent of anything the medication is doing.

Lean mass declines. Muscle loss accelerates through midlife, and estrogen withdrawal is part of why. Less muscle means less oxidative tissue consuming oxygen, which lowers absolute VO2 directly. This is the same process that drives sarcopenia risk, and it is why [muscle loss on a GLP-1 in menopause](/blog/muscle-loss-on-glp1-in-menopause-sarcopenia-risk) is a compounding rather than a parallel concern.

Cardiac and vascular changes. Estrogen influences vascular compliance and endothelial function. Its loss is associated with stiffer arteries and less favorable hemodynamics, which affect how efficiently oxygen is delivered to working muscle.

Training quality drops quietly. This one gets underweighted because it is behavioral rather than physiological, but it may be the largest single contributor. VO2 max is driven primarily by high-intensity work — efforts near your maximum. Through perimenopause, disrupted sleep, joint pain, and unpredictable energy make those efforts far less attractive. Many women maintain their exercise *volume* while their exercise *intensity* silently collapses, and volume without intensity maintains health but does not maintain VO2 max.

Iron status. Oxygen-carrying capacity depends on hemoglobin, and heavy perimenopausal bleeding is a leading cause of iron deficiency in midlife women. Low ferritin reduces aerobic capacity and exercise tolerance well before anemia appears on a blood count. If your fitness has dropped and your periods are heavy, ferritin belongs on the list before you conclude anything about training.

The encouraging counterpoint: none of these changes make fitness untrainable. Studies of structured aerobic training in postmenopausal women consistently show meaningful VO2 max improvements. The trajectory is modifiable; it just requires deliberately doing the thing that has become least appealing.

You raise the numerator. That means training that forces your cardiovascular system to adapt, supported by enough protein and resistance work to keep the muscle that consumes the oxygen.

Build an aerobic base with zone 2. Zone 2 is conversational-pace work — you can speak in full sentences but would rather not. It builds mitochondrial density and capillary networks, which raise the ceiling that intense work then pushes against. Aim for 150-180 minutes a week across three or four sessions. On a GLP-1, this is also the intensity that remains accessible on low-energy days; our guide to [zone 2 cardio on a GLP-1](/blog/zone-2-cardio-on-glp1-training-when-energy-is-low) covers how to train when fuel is limited.

Add one high-intensity session a week. This is the piece almost everyone skips, and it is the piece that moves VO2 max most. The classic protocol is 4 × 4 minutes at hard effort — around 90% of maximum heart rate, where you can manage only a few words — with 3 minutes of easy recovery between. Start with 2 or 3 intervals and build. One session weekly is enough to produce measurable change; two is plenty.

Protect the muscle. Resistance training at least twice weekly is non-negotiable during weight loss, both for absolute VO2 and for bone. See our [resistance training protocol for menopause](/blog/resistance-training-for-menopause-the-bone-density-protocol) and the broader [muscle preservation guide](/blog/muscle-preservation-on-glp1-strength-training-protein-guide).

Eat enough protein to support it. Training without adequate protein during a calorie deficit accelerates the exact lean mass loss you are trying to prevent. [Protein in menopause](/blog/protein-in-menopause-how-much-to-prevent-muscle-loss) covers the targets, and if appetite is the limiting factor, liquid protein is the practical workaround.

Schedule intensity away from your injection peak. Drug levels peak roughly one to three days after a weekly shot, and that is when appetite suppression, fatigue, and nausea are strongest. Most people find hard intervals go better later in the injection week. Fuel deliberately beforehand — training hard on an empty stomach on a GLP-1 is how sessions get abandoned.

For tracking your own trend, reasonably. For an accurate absolute number, no.

Consumer devices do not measure oxygen consumption. A true VO2 max test requires a metabolic cart, a mask, and a graded exercise protocol to volitional exhaustion. What your watch does instead is estimate — usually by modeling the relationship between your pace or power and your heart rate, then adjusting for your age, sex, and the weight you entered in the app.

That last input is the one that matters here. If your watch's estimate is a function of the weight in your profile, updating your weight will change your reported VO2 max with no exercise involved at all. Some platforms will show a step change the day after you sync a new weight. If you are losing weight steadily on a GLP-1, your estimate will drift upward continuously for reasons that have nothing to do with your heart.

The estimates also degrade in specific situations: interval-heavy sessions, hills, hot weather, poor wrist heart-rate accuracy, and any period where resting heart rate is elevated by illness or poor sleep. Chest-strap heart rate improves accuracy meaningfully.

More trustworthy alternatives for tracking real adaptation:

• •A fixed test you repeat. Time a set route or distance at maximum sustainable effort, under similar conditions, every 8-12 weeks. Improvement here is real.
• •Heart rate at a fixed pace. If your heart rate at a given speed drops over weeks, your cardiovascular system has adapted. This is one of the cleanest signals available and it is weight-adjusted only indirectly.
• •A laboratory test, if you want a genuine baseline. Increasingly available through sports medicine clinics and university labs.
• •Grip strength and DXA, to confirm you are keeping muscle while the scale moves. Our piece on [grip strength on a GLP-1](/blog/grip-strength-on-glp1-the-muscle-marker-that-matters) explains why it is such a useful proxy.

Use the watch for direction, not for truth — and be appropriately suspicious of an improvement that arrives during a month you did not train.

The most useful shift is from tracking a single reported metric to tracking a small set of things that are hard to fake.

Performance on a repeated test. A fixed route, a fixed distance, a fixed effort — timed every couple of months. This captures real change in a way no estimate can, and it is motivating in a way weight is not.

Heart rate recovery. How far your heart rate drops in the 60 seconds after stopping a hard effort. Faster recovery reflects better autonomic function and improving fitness, and it is independent of body weight.

Load in the gym. Whether you can lift more, or the same for more repetitions, than eight weeks ago. During rapid weight loss, maintaining strength is a genuine win and a good sign that lean mass is holding.

Grip strength. Cheap, quick, and a well-validated proxy for overall muscle function.

How you feel doing ordinary hard things. Stairs with shopping. A hill. Keeping up on a walk while talking. These are what fitness is actually *for*, and they are noticed long before any device registers a change.

The broader point applies well beyond VO2 max. On a GLP-1, several numbers improve mechanically because you weigh less, and it is easy to mistake that for physiological change. Some of it is genuinely beneficial — carrying less mass reduces joint load and makes activity more accessible, which then makes training possible. But the adaptations that extend healthspan come from the training, not the arithmetic.

Our guide to [tracking progress on a GLP-1 in menopause beyond the scale](/blog/tracking-progress-on-glp1-in-menopause-beyond-the-scale) covers the wider set of markers worth watching. And [body recomposition when the scale stalls](/blog/body-recomposition-on-glp1-when-the-scale-stalls) addresses the inverse problem — real progress that no number is showing you.